182 related articles for article (PubMed ID: 35476232)
21. BRAF V600E mutation in hairy cell leukemia: from bench to bedside.
Falini B; Martelli MP; Tiacci E
Blood; 2016 Oct; 128(15):1918-1927. PubMed ID: 27554081
[TBL] [Abstract][Full Text] [Related]
22. Historical overview of hairy cell leukemia.
Andritsos LA; Grever MR
Best Pract Res Clin Haematol; 2015 Dec; 28(4):166-74. PubMed ID: 26614894
[TBL] [Abstract][Full Text] [Related]
23. Development and validation of a real-time quantification assay to detect and monitor BRAFV600E mutations in hairy cell leukemia.
Schnittger S; Bacher U; Haferlach T; Wendland N; Ulke M; Dicker F; Grossmann V; Haferlach C; Kern W
Blood; 2012 Mar; 119(13):3151-4. PubMed ID: 22331186
[TBL] [Abstract][Full Text] [Related]
24. Variant B cell receptor isotype functions differ in hairy cell leukemia with mutated BRAF and IGHV genes.
Weston-Bell NJ; Forconi F; Kluin-Nelemans HC; Sahota SS
PLoS One; 2014; 9(1):e86556. PubMed ID: 24497953
[TBL] [Abstract][Full Text] [Related]
25. The Biology of Classic Hairy Cell Leukemia.
Bohn JP; Salcher S; Pircher A; Untergasser G; Wolf D
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360545
[TBL] [Abstract][Full Text] [Related]
26. BRAF inhibitor therapy in HCL.
Dietrich S; Zenz T
Best Pract Res Clin Haematol; 2015 Dec; 28(4):246-52. PubMed ID: 26614903
[TBL] [Abstract][Full Text] [Related]
27. Bone marrow and splenic histology in hairy cell leukaemia.
Wotherspoon A; Attygalle A; Mendes LS
Best Pract Res Clin Haematol; 2015 Dec; 28(4):200-7. PubMed ID: 26614898
[TBL] [Abstract][Full Text] [Related]
28. Hairy cell leukemia: a 'hair-raising' update.
Topp ZZ; Saven A
Expert Rev Hematol; 2014 Oct; 7(5):659-69. PubMed ID: 25148599
[TBL] [Abstract][Full Text] [Related]
29. Treatment of refractory hairy cell leukemia with a BRAF-inhibitor: lessons to be learnt.
Sári E; Nagy ZG; Baghy K; Rajnai H; Bödör C; Csomor J; Barna G; Rudas G; Kovalszky I; Demeter J
Pathol Oncol Res; 2014 Oct; 20(4):973-80. PubMed ID: 24789721
[TBL] [Abstract][Full Text] [Related]
30. Hairy cell leukemia cell lines expressing annexin A1 and displaying B-cell receptor signals characteristic of primary tumor cells lack the signature BRAF mutation to reveal unrepresentative origins.
Weston-Bell NJ; Hendriks D; Sugiyarto G; Bos NA; Kluin-Nelemans HC; Forconi F; Sahota SS
Leukemia; 2013 Jan; 27(1):241-5. PubMed ID: 22705994
[No Abstract] [Full Text] [Related]
31. Immunohistochemistry for BRAF V600E in the Differential Diagnosis of Hairy Cell Leukemia vs Other Splenic B-Cell Lymphomas.
Turakhia S; Lanigan C; Hamadeh F; Swerdlow SH; Tubbs RR; Cook JR
Am J Clin Pathol; 2015 Jul; 144(1):87-93. PubMed ID: 26071465
[TBL] [Abstract][Full Text] [Related]
32. [Molecular and therapeutic advances in Hairy cell leukemia].
Balsat M; Cornillon J
Bull Cancer; 2013 Oct; 100(10):1043-7. PubMed ID: 24103785
[TBL] [Abstract][Full Text] [Related]
33. Molecular detection of BRAF-V600E is superior to flow cytometry for disease evaluation in hairy cell leukaemia.
Rider T; Powell R; Gover R; Ansell R; Bastow S; Ghurye RR; Stewart H; Chevassut T
Hematol Oncol; 2014 Sep; 32(3):158-61. PubMed ID: 24123063
[No Abstract] [Full Text] [Related]
34. Genome-wide promoter methylation of hairy cell leukemia.
Arribas AJ; Rinaldi A; Chiodin G; Kwee I; Mensah AA; Cascione L; Rossi D; Kanduri M; Rosenquist R; Zucca E; Johnson PW; Gaidano G; Oakes CC; Bertoni F; Forconi F
Blood Adv; 2019 Feb; 3(3):384-396. PubMed ID: 30723113
[TBL] [Abstract][Full Text] [Related]
35. Hairy cell leukemia.
Dearden C
Best Pract Res Clin Haematol; 2015 Dec; 28(4):163-5. PubMed ID: 26614893
[No Abstract] [Full Text] [Related]
36. Hairy cell leukaemia-variant: Disease features and treatment.
Matutes E; Martínez-Trillos A; Campo E
Best Pract Res Clin Haematol; 2015 Dec; 28(4):253-63. PubMed ID: 26614904
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of vemurafenib in hairy-cell leukemia.
Samuel J; Macip S; Dyer MJ
N Engl J Med; 2014 Jan; 370(3):286-8. PubMed ID: 24428489
[No Abstract] [Full Text] [Related]
38. Correlation of the BRAF V600E mutation in hairy cell leukaemia with morphology, cytochemistry and immunophenotype.
Langabeer SE; O'Brien D; Liptrot S; Flynn CM; Hayden PJ; Conneally E; Browne PV; Vandenberghe E
Int J Lab Hematol; 2012 Aug; 34(4):417-21. PubMed ID: 22313586
[TBL] [Abstract][Full Text] [Related]
39. Recommendations of the SFH (French Society of Haematology) for the diagnosis, treatment and follow-up of hairy cell leukaemia.
Cornet E; Delmer A; Feugier P; Garnache-Ottou F; Ghez D; Leblond V; Levy V; Maloisel F; Re D; Zini JM; Troussard X;
Ann Hematol; 2014 Dec; 93(12):1977-83. PubMed ID: 24994538
[TBL] [Abstract][Full Text] [Related]
40. [Novelties in the diagnostics and therapy of hairy cell leukemia].
Sári E; Rajnai H; Dénes K; Bödör C; Csomor J; Körösmezey G; Tárkányi I; Eid H; Nagy Z; Demeter J
Magy Onkol; 2016 Jun; 60(2):137-44. PubMed ID: 27275640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
